Heparins in the new millennium: will unfractionated heparin survive? Introduction.
McClatchey
K D
KD
Department of Pathology, Loyola University Medical Center, Chicago, Illinois, USA.
Galvin
H M
HM
Galvin
R M
RM
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology; D014652:Vascular Diseases / Q000188:drug therapy / Q000209:etiology
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin